BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7455982)

  • 1. Platelet aggregates in ischemic heart disease.
    Schwartz MB; Hawiger J; Timmons S; Friesinger GC
    Thromb Haemost; 1980 Jul; 43(3):185-8. PubMed ID: 7455982
    [No Abstract]   [Full Text] [Related]  

  • 2. [A clinical trial of sheng-mai liquor in the treatment of ischemic heart disease].
    Yu Z; Chen KJ; Qian ZH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Jun; 15(3):144-7, 190-1. PubMed ID: 2963736
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet aggregation in 93 cases of coronary heart disease.
    Yu GR; Liang GR; Huang MX; Zheng DS; Huang DJ; Zhong DS; Xie XL; Yao GD; Zhang JL; Ding CY
    Chin Med J (Engl); 1985 Nov; 98(11):847-50. PubMed ID: 3938716
    [No Abstract]   [Full Text] [Related]  

  • 4. [The amount of thrombocyte alpha 2-adrenoreceptors in patients with different clinical variants in the course of ischemic heart disease].
    Prusskikh GA; Shartava ASh; Shakhov IuA; Gratsianskiĭ NA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):65-9. PubMed ID: 2557859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activity in acute and chronic ischemic heart disease, with reference to the type of hyperlipoproteinemia.
    Stăncioiu N; Scrobohaci ML; Zătreanu I; Orha I
    Med Interne; 1978; 16(4):395-403. PubMed ID: 749178
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of propranolol on the apoprotein spectrum of the blood plasma in patients with ischemic heart disease].
    Mikhin VP; Shuliak LN; Kameneva AM
    Vrach Delo; 1990 Feb; (2):24-6. PubMed ID: 2339543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the filtration pressure of the platelet aggregates in a group of coronary patients].
    Pagnan A; Donadon W; Barbieri E; Tonolli E; Dal Palù C
    Boll Soc Ital Cardiol; 1976; 21(6):696-80. PubMed ID: 1031066
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of abnormal platelet aggregability and change in exercise tolerance in patients with angina pectoris following oral propranolol.
    Frishman WH; Weksler B; Christodoulou JP; Smithen C; Killip T
    Circulation; 1974 Nov; 50(5):887-96. PubMed ID: 4609635
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet aggregation abnormalities in angina pectoris. A study before and after propranolol therapy.
    Kasturi J; Kasturi TE; Saraya AK; Bhatia ML
    J Assoc Physicians India; 1979 Jul; 27(7):575-82. PubMed ID: 396301
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy in coronary heart disease.
    Frishman WH
    Hosp Pract (Hosp Ed); 1982 May; 17(5):73-86. PubMed ID: 7044945
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P; Abbadessa V; Pecorella M; Cajozzo A
    Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypoxanthine content in the peripheral venous blood in ischemic heart disease with attacks of stenocardia and in osteochondrisis of the cervico-thoracic part of the spine].
    Naumova VV; Gneushev ET; Bogoslovskiĭ VA
    Ter Arkh; 1979; 51(5):22-7. PubMed ID: 451916
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiplatelet therapy and platelet function studies in elderly patients with ischemic heart disease--evaluation of whole blood platelet aggregation].
    Kawamura H; Kodama H; Takeuchi G; Kohsaka K; Suzuki S; Nitta M; Takada K; Mitomo Y; Yamamoto M
    Rinsho Ketsueki; 1986 Oct; 27(10):1815-22. PubMed ID: 3820607
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet aggregation in atherosclerotic disease after administration of lysine acetylsalicylate].
    Evangelisti GB; Faggioli F; Garagnani A; Lama G
    Minerva Cardioangiol; 1978 Jun; 26(6):447-60. PubMed ID: 673198
    [No Abstract]   [Full Text] [Related]  

  • 16. [Properties of thrombocytes in patients with ischemic heart disease].
    Sopina NV
    Vrach Delo; 1987 Apr; (4):39-41. PubMed ID: 3617634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemostasis in ischemic heart disease patients undergoing hyperbaric oxygenation].
    Goliakov VN; Eroshina VA; Zimin IuV; Semiletova VI
    Klin Med (Mosk); 1986 Feb; 64(2):92-5. PubMed ID: 3702304
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of the treatment of ischemic heart disease with delayed-action verapamil].
    Zharov EI; Styrova TK; Barinov VG; Martynov AI; Galichenko IV; Sedov VP; Vertkin AL
    Klin Med (Mosk); 1991 Aug; 69(8):48-50. PubMed ID: 1791709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in hemostasis in ischemic heart disease in advanced age].
    Tóthová E; Petrásová D; Mudronová B
    Vnitr Lek; 1991; 37(7-8):639-44. PubMed ID: 1755203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of sodium ferulate on platelet aggregation and platelet thromboxane A2 in patients with coronary heart disease].
    Gao SW; Chen ZJ
    Zhong Xi Yi Jie He Za Zhi; 1988 May; 8(5):263-5, 259. PubMed ID: 3197226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.